348 results match your criteria Clinical Reviews in Allergy & Immunology [Journal]


Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).

Br J Dermatol 2018 May 19;178(5):e332-e341. Epub 2018 Apr 19.

University of São Paulo, Campinas, Brazil.

This is the report from the fifth meeting of the Harmonising Outcome Measures for Eczema initiative (HOME V). The meeting was held on 12-14 June 2017 in Nantes, France, with 81 participants. The main aims of the meeting were (i) to achieve consensus over the definition of the core domain of long-term control and how to measure it and (ii) to prioritize future areas of research for the measurement of the core domain of quality of life (QoL) in children. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjd.16543DOI Listing
May 2018
1 Read

The challenge of treating orphan disease.

Clin Rev Allergy Immunol 2014 Dec;47(3):259-63

Department of Internal Medicine, Centro Hospitalar São João, 4200-319, Porto, Portugal,

Uncommon or orphan diseases are less frequently addressed in mainstream medical journals and, as a consequence, their understanding and clinical recognition may rely on case series or anecdotal data with limited guidelines and management directions. The study of selected underrepresented autoimmune and allergy conditions is the subject of the present issue of Clinical Reviews in Allergy and Immunology to provide peculiar perspectives on common and rare themes. First, allergy remains a major concern for physicians worldwide despite the limited developments over the past years, particularly for antigens such as mite or Alternaria alternata, and due to the increasing incidence of drug hypersensitivity. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12016-014-8462-7DOI Listing
December 2014
6 Reads

Unique topics and issues in rheumatology and clinical immunology.

Authors:
Carlo Selmi

Clin Rev Allergy Immunol 2014 Aug;47(1):1-5

Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, CA, USA,

Clinicians are facing unexpected issues in everyday practice, and these may become counterintuitive or challenging. Illustrative examples are provided by the hypersensitivity to universally used immunosuppressants such as corticosteroids or antibiotics such as beta-lactam. Secondly, additional issues are represented by the discovery of new pathogenetic mechanisms involved in rheumatoid and psoriatic arthritis or other chronic inflammatory diseases, genomic susceptibility to enigmatic diseases such as giant cell arteritis, or the shared role of specific mediators such as semaphorins. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12016-014-8441-z
Publisher Site
http://dx.doi.org/10.1007/s12016-014-8441-zDOI Listing
August 2014
8 Reads

Less travelled roads in clinical immunology and allergy: drug reactions and the environmental influence.

Clin Rev Allergy Immunol 2013 Aug;45(1):1-5

University of Milan, Milan, Italy.

Allergy and clinical immunology are examples of areas of knowledge in which working hypotheses are dominant over mechanistic understanding. As such, sometimes scientific efforts follow major streams and overlook some epidemiologically prevalent conditions that thus become underestimated by the research community. For this reason, we welcome the present issue of Clinical Reviews in Allergy and Immunology that is dedicated to uncommon themes in clinical immunology and allergy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12016-013-8381-zDOI Listing
August 2013
7 Reads

The autoimmune side of heart and lung diseases.

Clin Rev Allergy Immunol 2013 Feb;44(1):1-5

The Zabludowicz Center for Autoimmune Diseases, Chaim Sheba Medical Center, 52621 Tel-Hashomer, Israel.

The elevated cardiovascular morbidity in rheumatoid arthritis, systemic lupus erythematosus, and the antiphospholipid syndrome is well known, as well as the pulmonary involvement observed in these conditions and to a major extent in systemic sclerosis. These manifestations constitute a major challenge for clinicians involved in patient management. Moreover, several issues regarding the link between autoimmune rheumatic diseases and cardio pulmonary morbidity remain largely enigmatic. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12016-012-8335-xDOI Listing
February 2013
2 Reads

Mechanisms and pathophysiology of autoimmune disease.

Authors:
Wesley H Brooks

Clin Rev Allergy Immunol 2012 Feb;42(1):1-4

Experimental HTS Core, SRB-3, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612-9416, USA.

The first textbook on autoimmunity was published by Ian Mackay and McFarland Burnett in 1963. It was the first attempt to summarize existing knowledge on human autoimmunity. Since that time, there have been tens of thousands of experimental papers and numerous textbooks that focus on the diagnosis and treatment of human autoimmunity. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12016-011-8298-3DOI Listing
February 2012
1 Read

The revolution of epigenetics in the field of autoimmunity.

Authors:
Yves Renaudineau

Clin Rev Allergy Immunol 2010 Aug;39(1):1-2

EA2219 Immunology and Pathology, IFR148 ScinBios, Université de Brest, Brest, France.

Autoimmunity is believed to develop when genetically predisposed individuals encounter epigenetic modifications in response to environmental factors. Recent advances in the understanding of epigenetic mechanisms, their contribution to the immune function, and to the development of autoimmunity are presented in this special issue of Clinical Reviews in Allergy and Immunology. Potential new therapeutic strategies and biomarkers are also addressed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12016-009-8171-9DOI Listing
August 2010
3 Reads

Crosstalk of liver, bile ducts and the gut.

Authors:
Ulrich Beuers

Clin Rev Allergy Immunol 2009 Feb;36(1):1-3

Department of Gastroenterology and Hepatology, G4-213 Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE, Amsterdam, The Netherlands.

A complex interplay of liver, bile ducts, and the gut critically determines functioning of these organs in health and disease. Biochemical and physiological aspects of their interaction and the role of inflammatory cells, cytokines, bile acids, visceral hormones, neuropeptides and other messengers in the pathogenesis of model immune-mediated hepatobiliary disorders are discussed in the actual issue of Clinical Reviews in Allergy and Immunology. Potential molecular targets for future therapeutic approaches are also addressed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12016-008-8084-zDOI Listing
February 2009
1 Read

Whither autoimmunity: the lessons of anti-CCP and B cell depletion.

Clin Rev Allergy Immunol 2008 Feb;34(1):1-3

Department of Medicine B and Center for Autoimmune Diseases, Sheba Medical Center, Affiliated to Tel-Aviv University, Tel-Hashomer, 52621, Israel.

The most difficult component to understand in autoimmune disease has been the issue of causation. In contrast, there have been enormous gains in improved diagnostics as well as improved therapy. Indeed, the use of biologics have changed the profile of numerous autoimmune diseases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12016-007-8014-5DOI Listing
February 2008
1 Read

Cutting edge issues in allergy and clinical immunology.

Clin Rev Allergy Immunol 2007 Feb;32(1):1-2

AESKU.KIPP Institute and AESKU.DIAGNOSTICS, Wendelsheim, Germany.

Approximately every 5 yr, Clinical Reviews in Allergy and Immunology deviates from its usual practice of publishing volumes devoted to one theme to including papers that cover a range of subjects. This issue is one such exception and arose following a symposium at the International Institute for Research in Autoimmune Diseases named AESKU.KIPP Institute at their Wendelsheim facility. Read More

View Article

Download full-text PDF

Source
February 2007
1 Read

Immunosuppressive agents and asthma.

Authors:
T Fukuda

Clin Rev Allergy 1994 ;12(1):95-108

Department of Internal Medicine and Clinical Immunology, Dokkyo University School of Medicine, Tochigiken, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02815512DOI Listing
September 1994
1 Read

Leukotriene and thromboxane antagonists.

Clin Rev Allergy 1994 ;12(1):79-93

Minase Research Institute, Ono Pharmaceutical Co., Ltd., Osaka, Japan.

It has been suggested that arachidonate metabolites, leukotrienes, and thromboxane may play important roles in the pathogenesis of bronchial asthma. Biologic activities of these mediators are much more potent than those of histamine and acetylcholine on a molar basis in inducing bronchoconstriction, increase in microvascular permeability, formation of mucosal edema, and mucus secretion, which are characteristic features of bronchial asthma. Furthermore, recent studies have demonstrated the presence of these mediators in plasma, BALF, and urine in asthmatic patients after allergen challenge. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02815511DOI Listing
September 1994
1 Read

Novel approaches in immunotherapy.

Authors:
J M Saint-Remy

Clin Rev Allergy 1994 ;12(1):23-42

Allergy and Clinical Immunology Unit, Université Catholique de Louvain, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02815508DOI Listing
September 1994
1 Read

Potassium channel openers and asthma.

Authors:
J Morley

Clin Rev Allergy 1994 ;12(1):109-20

Department of Applied Pharmacology, National Heart and Lung Institute, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02815513DOI Listing
September 1994
1 Read

The legal liability of the Institutional Review Board.

Authors:
M Cohen P A Palafox

Clin Rev Allergy 1994 ;12(2):211-8

El Paso Institute of Medical Research and Development, TX 79902.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02802356DOI Listing
December 1994
1 Read

New perspectives in information retrieval.

Authors:
T L Knott U K Scott

Clin Rev Allergy 1994 ;12(2):201-10

Library of the Health Sciences, Texas Tech University Health Sciences Center, El Paso 79905.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02802355DOI Listing
December 1994
1 Read

Controversy in allergy. Neurologic allergy.

Authors:
L E Mansfield

Clin Rev Allergy 1994 ;12(2):181-99

Texas Tech School of Medicine, El Paso.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02802354DOI Listing
December 1994
1 Read

The role of food in the pathogenesis of migraine headache.

Authors:
T R Vaughan

Clin Rev Allergy 1994 ;12(2):167-80

Allergy/Immunology Service, Fitzsimons Army Medical Center, Aurora, CO 80045-5001.

Recent textbooks of neurology and internal medicine cite food, or pharmacologic agents in foods, as provokers of migraine (1,2). Nevertheless, this area remains controversial. Many authorities recognize foods containing pharmacologic agents, such as tyramine, as possible provokers of migraine. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02802353DOI Listing
December 1994
1 Read

In vitro allergy testing. Past, present, and future.

Authors:
L L Perelmutter

Clin Rev Allergy 1994 ;12(2):151-65

Department of Pediatrics, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02802352DOI Listing
December 1994
1 Read

The use of the clinical immunology laboratory.

Clin Rev Allergy 1994 ;12(2):125-49

Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis 95616.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02802351DOI Listing
December 1994
1 Read

Office-based clinical issues.

Authors:
L E Mansfield

Clin Rev Allergy 1994 ;12(2):121-4

Texas Tech University, Health Sciences Center, El Paso.

View Article

Download full-text PDF

Source
December 1994
1 Read

Antihistamines in the treatment of asthma.

Authors:
S T Holgate

Clin Rev Allergy 1994 ;12(1):65-78

Immunopharmacology Group, Southampton General Hospital, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02815510DOI Listing
September 1994
1 Read

Inhaled beta-2 agonists and steroids. Present state and future perspectives.

Authors:
A M Clauzel

Clin Rev Allergy 1994 ;12(1):43-64

CHR Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02815509DOI Listing
September 1994
1 Read

Anti-neutrophil cytoplasmic autoantibodies (ANCA) and vasculitis.

Authors:
B Baslund A Wiik

Clin Rev Allergy 1994 ;12(3):297-304

Department of Autoimmunology, Statens Seruminstitut, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02802324DOI Listing
January 1995
1 Read

Antiphospholipid antibodies. A marker for thrombosis and recurrent abortion.

Clin Rev Allergy 1994 ;12(3):287-96

Lupus Arthritis Research Unit, Rayne Institute, St. Thomas' Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02802323DOI Listing
January 1995
1 Read

Anti-endothelial cell antibodies and autoimmune diseases.

Clin Rev Allergy 1994 ;12(3):275-86

Istituto di Medicina Interna, University of Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02802322DOI Listing
January 1995
1 Read

Anti-Ro(SSA) and anti-La(SSB) antibodies in autoimmune rheumatic diseases.

Clin Rev Allergy 1994 ;12(3):253-74

Laboratory of Immunology, Brest University Medical School, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02802321DOI Listing
January 1995
1 Read

Anti-DNA antibodies. Their idiotypes and SLE.

Clin Rev Allergy 1994 ;12(3):237-52

Department of Medicine B, Soroka Medical Center, Beer-Sheva, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02802320DOI Listing
January 1995
1 Read

Antitopoisomerase and anticentromere antibodies in the sclerodermatosus complex.

Authors:
C G Kallenberg

Clin Rev Allergy 1994 ;12(3):221-35

Department of Clinical Immunology, University Hospital Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02802319DOI Listing
January 1995
1 Read

Paf. A mediator in search of a disease.

Authors:
B B Vargaftig

Clin Rev Allergy 1994 ;12(4):419-21

Unité de Pharmacologie cellulaire, INSERM 385, 25, Paris, France.

View Article

Download full-text PDF

Source
June 1995
1 Read

Clinical experience with platelet-activating factor antagonists. Past, present, and near future.

Authors:
P Guinot

Clin Rev Allergy 1994 ;12(4):397-417

University of California, Department of Internal Medicine, School of Medicine, Davis 95616-8660, USA.

View Article

Download full-text PDF

Source
June 1995
1 Read

Platelet-activating factor and the cytokine network in inflammatory processes.

Clin Rev Allergy 1994 ;12(4):381-95

Department of Microbiology and Immunology, UCLA School of Medicine 90024, USA.

View Article

Download full-text PDF

Source
June 1995
1 Read

Platelet-activating factor antagonists.

Clin Rev Allergy 1994 ;12(4):361-80

Institut Henri Beaufour, Le Plessis Robinson, France.

View Article

Download full-text PDF

Source
June 1995
1 Read

Structural and (patho)physiological diversity of PAF.

Clin Rev Allergy 1994 ;12(4):329-59

Department of Pathology, University of Texas Health Science Center, San Antonio 78284, USA.

View Article

Download full-text PDF

Source
June 1995
1 Read

Metabolic processing of PAF.

Authors:
F Snyder

Clin Rev Allergy 1994 ;12(4):309-27

Medical Sciences Division, Oak Ridge Institute for Science and Education, Oak Ridge Associated Universities, TN 37831-0117, USA.

View Article

Download full-text PDF

Source
June 1995
1 Read

Inflammatory membrane-derived lipids and their antagonists.

Authors:
P Guinot

Clin Rev Allergy 1994 ;12(4):305-7

Division of Allergy/Rheumatology University of California-Davis, USA.

View Article

Download full-text PDF

Source
June 1995
1 Read

Modulation of allergen-specific antibody responses by T-cell-based peptide vaccine(s). Principles and potential.

Authors:
S S Mohapatra

Clin Rev Allergy 1994 ;12(1):3-22

Department of Immunology, University of Manitoba, Winnipeg, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02815507DOI Listing
September 1994
1 Read

Loratadine. A review of recent findings in pharmacology, pharmacokinetics, efficacy, and safety, with a look at its use in combination with pseudoephedrine.

Clin Rev Allergy 1993 ;11(1):89-110

Medical Marketing, Schering-Plough, Kenilworth, NJ 07033.

Antihistamines are considered first-line therapy for the relief of symptoms from allergic rhinitis and chronic urticaria. The newer, second-generation, nonsedating antihistamines reduce the central nervous system and anticholinergic side effects commonly found with previous drugs. The availability of H1-receptor antagonists that produce therapeutic effects without causing unwanted CNS effects fulfills an important practical need, since these drugs are clearly preferable in patients who drive or operate heavy machinery, or who are involved in activities requiring full alertness. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02802295DOI Listing
August 1993
1 Read

Cetirizine. An updated review of its pharmacological properties and therapeutic efficacy.

Authors:
J P Rihoux S Mariz

Clin Rev Allergy 1993 ;11(1):65-88

UCB S.A., Chemin Du Foriest, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02802294DOI Listing
August 1993
1 Read

Terfenadine. The first nonsedating antihistamine.

Authors:
H C Masheter

Clin Rev Allergy 1993 ;11(1):5-34

Marion Merrell Dow Ltd., Uxbridge, Middlesex, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02802292DOI Listing
August 1993
1 Read

Astemizole. A nonsedating antihistamine with fast and sustained activity.

Authors:
M M Janssens

Clin Rev Allergy 1993 ;11(1):35-63

International Clinical R&D, Allergy, Janssen Research Foundation, Beerse, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF02802293DOI Listing
August 1993
1 Read

Chemical additives in seafood products.

Clin Rev Allergy 1993 ;11(2):261-91

University of Nebraska, Department of Food Science and Technology, Lincoln 68583-0919.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/BF02914474.pdf
Web Search
December 1993
1 Read

Seafood toxins.

Clin Rev Allergy 1993 ;11(2):241-60

Center for Drug Evaluation and Research, Division of Oncologic and Pulmonary Drug Products, Rockville, MD.

View Article

Download full-text PDF

Source
December 1993
1 Read

Occupational reactions in the seafood industry.

Authors:
J L Malo A Cartier

Clin Rev Allergy 1993 ;11(2):223-40

Department of Chest Medicine, Université de Montréal, Hôpital du Sacré-Coeur, Canada.

View Article

Download full-text PDF

Source
December 1993
1 Read

Hypersensitivity reactions to crustacea and mollusks.

Clin Rev Allergy 1993 ;11(2):201-22

Oschner Foundation and Clinic, New Orleans, LA.

View Article

Download full-text PDF

Source
December 1993
2 Reads

Allergic reactions to fish.

Clin Rev Allergy 1993 ;11(2):183-200

Department of Medicine, Tulane Medical Center, New Orleans, LA.

A wide variety of fish are known to induce allergic reactions following ingestion or inhalation of vapors by sensitized individuals. Although the exact prevalence of fish sensitivity is not known, fish are among the most important food allergens; and as consumption of fish increases, rates of sensitization are expected to increase. Diagnosis of fish allergy is aided by clinical history, skin prick testing, and in vitro assays; however, double-blind placebo-controlled food challenges are the most reliable method to confirm fish allergy and to identify putative species. Read More

View Article

Download full-text PDF

Source
December 1993
1 Read

Phylogeny of commercially important seafood and description of the seafood industry.

Clin Rev Allergy 1993 ;11(2):159-81

Louisiana Cooperative Extension Service, Louisiana Agricultural Center.

View Article

Download full-text PDF

Source
December 1993
1 Read

Seafood allergy. Introduction.

Authors:
S B Lehrer

Clin Rev Allergy 1993 ;11(2):155-7

Tulane University Medical Center, New Orleans, LA.

View Article

Download full-text PDF

Source
December 1993
1 Read

New therapeutic approaches in atopic dermatitis.

Authors:
K D Cooper

Clin Rev Allergy 1993 ;11(4):543-59

Department of Dermatology, University of Michigan Medical School, Ann Arbor.

Novel approaches to the therapy for atopic dermatitis (AD) can now be considered because of recent advances in the pathogenesis of the disease. Several of these concepts are being tested in clinical trials. The effectiveness of cyclosporin A, plus reports of adoptive transfer of AD, or its clearing, following bone marrow transplantation, verify the criticalness of immune cells in AD pathogenesis. Read More

View Article

Download full-text PDF

Source
May 1994
1 Read

Immunopharmacologic aspects of atopic dermatitis.

Clin Rev Allergy 1993 ;11(4):523-41

Oregon Health Sciences University, Portland.

View Article

Download full-text PDF

Source
May 1994
2 Reads